Almanack Investment Partners »

Taysha Gene Therapies shares owned by Almanack Investment Partners

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Almanack Investment Partners from 13F filings

Historical chart of Almanack Investment Partners investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Almanack Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Almanack Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $306k 45k 6.81

More positions owned by Almanack Investment Partners

Ea Series Trust Gadsdn Dyn Mlt (GDMA)
Verizon Communications (VZ)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Ishares Tr 0-3 Mth Treasury (SGOV)
Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Fund Em Equi Etf (FNDE)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Blackrock Etf Trust Isha I In Te Etf (BAI)
First Tr Exchange-traded Nasdq Cln Edge (GRID)
Wisdomtree Tr Japn Hedge Eqt (DXJ)
NVIDIA Corporation (NVDA)
Vanguard Malvern Fds Strm Infproidx (VTIP)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Apple (AAPL)
Roundhill Etf Trust Memory Etf

View all positions for Almanack Investment Partners

Top funds holding Taysha Gene Therapies

venBio Select Advisor
RA Capital Management
Goldman Sachs Group
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Capital Management
State Street Corporation
Siren
Octagon Capital Advisors
Geode Capital Management
Polar Capital Holdings
MPM Oncology Impact Management

View all funds holding Taysha Gene Therapies